Advanced Search


Study ID Status Title Patient Level Data
MET111648 Completed A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects with Solid Tumors Study Listed on
MHE104317 Recruiting An Open-Label Compassionate Use access and Long-Term Access Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome
MKC101614 Completed A 28-day, randomised, double-blind, placebo-controlled study to assess the safety, tolerability, anti-inflammatory effect and steady-state pharmacokinetics of SB-681323 7.5 mg per day in patients with chronic obstructive pulmonary disease.
MKI102428 Completed A 12-week, randomised, double-blind, placebo-controlled study to assess the anti-inflammatory activity, efficacy and safety of GW856553 in subjects with chronic obstructive pulmonary disease (COPD) Study Listed on
MKI106209 Completed A randomised, double-blind, placebo-controlled parallel study to assess the safety, tolerability,pharmacodynamics and steady state pharmacokinetics of repeated doses of GW856553 in patients with COPD
MKN106762 Completed A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma
MMRV (208136) - Meta-analysis Completed Integrated Summary Output (ISO) on febrile convulsions
MOT107043 Completed A First-Time-in-Human Randomized Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of the Oral Motilin Receptor Agonist GSK962040, in Male and Female Healthy Subjects Study Listed on
MOT109681 Completed A randomized, double-blind, ascending dose trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics, of repeat doses of motilin receptor agonist GSK962040 in male and female healthy volunteers Study Listed on
MT400-108 Completed Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets Administered Two Hours Apart on Chromosomal Aberrations in Peripheral Blood Lymphocytes
MT400-301 Completed A Double-Blind Multicenter, Randomized, Placebo-Controlled Single dose study to evaluate the safety and efficacy of Trexima in the acute treatment of migrane headaches
MT400-302 Completed A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy opf Trexima in the Acute Treatment of Migraine Headaches
MT400-303 Completed An Open-Label, Repeat Dose Study Of The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
NAA104606 Completed A Multi Centre, Double-Blind, Double-Dummy, Placebo-Controlled, Randomised, Adaptive, Dose-Range Study To Evaluate the Safety and Efficacy of SB-773812 Administered Once Daily for 12 Weeks in Adults With Schizophrenia
NAA105416 Completed Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole 400mg on Pharmacokinetics of SB-773812 20mg.
NAA105737 Completed A single blind, double dummy, placebo controlled, randomized, 2 period crossover study to assess the relative bioavailability of a 120mg tablet compared to two 60 mg SB-773812 tablets in healthy volunteers
NAI108166 Withdrawn Phase 1, Open-Label Study to Evaluate Potential Pharmacokinetic Interactions Between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects
NAP109169 Completed An open, randomised, two-period crossover study to investigate the effect of food on the pharmacokinetics of GW273225 administered immediately after food and administered in the fasted state to healthy male and female volunteers.
NEC107055 Withdrawn An Open-label Evaluation of Drug Interactions, Safety, Tolerability and Efficacy of GW273225 Add-on Treatment of Partial Seizures, Whether or Not Secondarily Generalized
NEC107110 Terminated An open, repeat dose study to investigate the effect of co-administration of the combined oral contraceptive pill (COC) and GW273225 on the pharmacokinetics of the COC and to investigate the effects of the COC on the pharmacokinetics of GW273225 in healthy female subjects
NKB104846 Terminated A randomized, double-blind, placebo-controlled, crossover study (Part 1) and parallel group design study (Part 2) to evaluate the effects of GW679769 on Current Perception Threshold (CPT) following a single dose and the effect on CPT and symptoms of overactive bladder (OAB) following 28 days of repeat dosing in Patients with Neurogenic Bladder due to Upper Motor Neuron (UMN) Disease
NKB105022 Completed NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder symptoms
NKD20006 Completed An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Fixed-Dose Study Comparing the Efficacy and Safety of GW597599B or Paroxetine to Placebo in Moderately to Severely Depressed Patients with Major Depressive Disorder Study Listed on
NKF100092 Completed A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Evaluating the Efficacy and Safety of GW679769 in Subjects with Major Depressive Disorder.
NKF100096 Completed A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major depressive Disorder (MDD) Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.